Status:
COMPLETED
Effectiveness of Aquatic Therapy in Children With Duchenne and Becker Muscular Dystrophy
Lead Sponsor:
Gaziosmanpasa Research and Education Hospital
Conditions:
Duchenne or Becker Muscular Dystrophy
Eligibility:
All Genders
5-18 years
Phase:
NA
Brief Summary
The purpose of this study is ; to evaluate the effects of aquatic therapy applied in addition to conventional physical therapy on balance, functionality and quality of life in children with Duchenne a...
Detailed Description
Duchenne and Becker muscular dystrophy is the most common type of muscular dystrophy in childhood caused by a mutation of the DMD gene. Progressive muscle weakness is the main symptom, as muscle fiber...
Eligibility Criteria
Inclusion
- Diagnosed with Duchenne Muscular Dystrophy or Becker Muscular Dystrophy by a neurologist
- Between the ages of 5-18, with ongoing ambulation
- Co-operating with the physiotherapist's practices
Exclusion
- Those who will not be able to perform the evaluation parameters
- Have a serious systemic disease that may interfere with exercise
- Injury and/or surgery in the last 6 months
- Receive gene therapy
- In the presence of contraindications to aquatic therapy such as excessive fear of water, behavioral problems, shortness of breath at rest, infection, incontinence, known chlorine allergy, open wound, acute systemic disease, epilepsy, tracheotomy, permanent drain, immunodeficiency
Key Trial Info
Start Date :
November 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06186310
Start Date
November 5 2023
End Date
February 29 2024
Last Update
March 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziosmanpasa Research and Education Hospital
Istanbul, Gaziosmanpaşa, Turkey (Türkiye), 34255